Unlock stock picks and a broker-level newsfeed that powers Wall Street.
NasdaqCM - Nasdaq Real Time Price USD

Scienture Holdings, Inc. (SCNX)

Compare
1.5500
-0.1000
(-6.06%)
At close: March 28 at 4:00:01 PM EDT
1.5699
+0.02
+(1.28%)
After hours: March 28 at 7:45:52 PM EDT
Loading Chart for SCNX
  • Previous Close 1.6500
  • Open 1.6600
  • Bid 1.4500 x 200
  • Ask 1.6900 x 100
  • Day's Range 1.1700 - 1.6627
  • 52 Week Range 1.0000 - 23.7700
  • Volume 1,057,988
  • Avg. Volume 2,933,266
  • Market Cap (intraday) 13.935M
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) -20.2200
  • Earnings Date Jun 24, 2025 - Jun 30, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date Jul 19, 2024
  • 1y Target Est --

Scienture Holdings, Inc. operates as health services IT company. It offers an online web-based buying and selling platform for licensed pharmaceutical wholesalers to sell brand, generic, and non-drug products and services to government organizations, hospitals, clinics, and independent pharmacies. Scienture Holdings, Inc. is headquartered in Tampa, Florida.

scienture.com

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: SCNX

View More

Performance Overview: SCNX

Trailing total returns as of 3/28/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

SCNX
74.38%
S&P 500 (^GSPC)
5.11%

1-Year Return

SCNX
83.78%
S&P 500 (^GSPC)
6.22%

3-Year Return

SCNX
92.91%
S&P 500 (^GSPC)
21.97%

5-Year Return

SCNX
97.26%
S&P 500 (^GSPC)
119.59%

Compare To: SCNX

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: SCNX

View More

Valuation Measures

Annual
As of 3/28/2025
  • Market Cap

    13.94M

  • Enterprise Value

    16.11M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.45

  • Price/Book (mrq)

    0.16

  • Enterprise Value/Revenue

    2.26

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    6,634.66%

  • Return on Assets (ttm)

    -15.65%

  • Return on Equity (ttm)

    -45.83%

  • Revenue (ttm)

    136.64k

  • Net Income Avi to Common (ttm)

    -18.24M

  • Diluted EPS (ttm)

    -20.2200

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    308.1k

  • Total Debt/Equity (mrq)

    4.47%

  • Levered Free Cash Flow (ttm)

    -14.07M

Research Analysis: SCNX

View More

Company Insights: SCNX

Research Reports: SCNX

View More

People Also Watch